XML 31 R23.htm IDEA: XBRL DOCUMENT v3.23.3
STOCK COMPENSATION (Tables)
6 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Schedule of share-based compensation expense
                
   Three Months
Ended
September 30,
2023
   Three Months
Ended
September 30,
2022
   Six Months
Ended
September 30,
2023
   Six Months
Ended
September 30,
2022
 
Vesting of stock options and restricted stock units  $257,181   $313,538   $507,295   $528,975 
Total stock-based compensation expense  $257,181   $313,538   $507,295   $528,975 
                     
Weighted average number of common shares outstanding – basic and diluted   2,483,649    2,074,500    2,457,711    1,813,018 
                     
Basic and diluted loss per common share attributable to stock-based compensation expense  $(0.10)  $(0.15)  $(0.21)  $(0.29)
Schedule of options outstanding that have vested and are expected to vest
            
   Number of
Shares
   Weighted
Average
Exercise
Price
   Weighted
Average
Remaining
Contractual
Term in
Years
 
Vested   86,180   $24.60    7.49 
Expected to vest   70,884   $20.87    8.04 
Total   157,064           
Schedule of stock option activity
                 
    Amount     Range of
Exercise Price
    Weighted
Average
Exercise
Price
 
Stock options outstanding at March 31, 2023     171,826     $ 6.90 – 1,425     $ 22.39  
Exercised         $     $  
Granted         $     $  
Cancelled/Expired     14,762     $ 12.10 - 750     $ 13.80  
Stock options outstanding at September 30, 2023     157,064     $ 6.90 – 1,425     $ 22.92  
Stock options exercisable at September 30, 2023     86,180     $ 12.80 – 1,425     $ 24.60